Coq10 may be cost effective and safe way of reducing liver disease

Babies born to mothers on low protein diets while pregnant may benefit from dietary supplementation of co-enzyme Q10 to prevent developing liver disease and cirrhosis in later life, new research from the United Kingdom suggests. “Our findings that a maternal low-protein diet in utero followed by accelerated postnatal growth (recuperated) confers a higher risk of oxidative damage, proinflammatory changes, and liver fibrosis suggest that the early environment is an important determinant of an individual’s risk of developing complications of fatty liver disease,” the study authors wrote in the American Journal of Clinical Nutrition.

To continue reading this article, please Log In or Sign Up for access.